There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:DANA-FARBER CANCER INSTITUTE, INC.
Jump to navigation
Jump to search
Pages in category "DANA-FARBER CANCER INSTITUTE, INC."
The following 6 pages are in this category, out of 6 total.
1
- 18200950. COMPOUNDS FOR TAU PROTEIN DEGRADATION simplified abstract (DANA-FARBER CANCER INSTITUTE, INC.)
- 18224865. GENERATION OF ANTI-TUMOR T CELLS simplified abstract (DANA-FARBER CANCER INSTITUTE, INC.)
- 18234229. METHODS FOR SENSITIZING CANCER CELLS TO T CELL-MEDIATED KILLING BY MODULATING MOLECULAR PATHWAYS simplified abstract (DANA-FARBER CANCER INSTITUTE, INC.)
- 18461820. MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors simplified abstract (DANA-FARBER CANCER INSTITUTE, INC.)
- 18464360. C-RAF Mutants that Confer Resistance to RAF Inhibitors simplified abstract (DANA-FARBER CANCER INSTITUTE, INC.)
- 18503556. COMPOUNDS AND METHODS FOR TREATING CANCER simplified abstract (DANA-FARBER CANCER INSTITUTE, INC.)